GTC Biotherapeutics (fka GTCB)

[keitern]

Dew, re. "U.S. ATryn time line" I believe the FDA trial would start in PIII. Could you elaborate on that somewhat; exactly how do we know that we have satisfied PI, PII at the FDA and then please comment on whether you think the investing public, maybe institutional as well, is fully up to speed on this aspect, the likely hood of fast track, etc. Thanks.